Events | 2020.01.25
Taiho Oncology Presents Data on LONSURF® (trifluridine and tipiracil) and Futibatinib (TAS-120) at ASCO 2020 Gastrointestinal Cancers Symposium (ASCO GI)
PRINCETON, N.J., Jan. 25, 2020 /PRNewswire/ -- Taiho Oncology, Inc. announced today the presentation of a pooled analysis for hematologic adverse events of the global Phase III TAGS and RECOURSE trials evaluating LONSURF® (trifluridine and tipiracil) in patients with metastatic colorectal...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]mposium-asco-gi-300993200.html
